1 – 10 of 181
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
- The role of SRC family kinases in FLT3 signaling
- The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
- 2018
- Internal tandem duplication mutations in the tyrosine kinase domain of FLT3 display a higher oncogenic potential than the activation loop D835Y mutation
- SRC-like adaptor protein 2 (SLAP2) is a negative regulator of KIT-D816V-mediated oncogenic transformation
- XK-related protein 5 (XKR5) is a novel negative regulator of KIT/D816V-mediated transformation
- Bruton’s tyrosine kinase potentiates ALK signaling and serves as a potential therapeutic target of neuroblastoma
- De novo activating mutations drive clonal evolution and enhance clonal fitness in KMT2A-rearranged leukemia
- 2017
- The Src family kinase LCK cooperates with oncogenic FLT3/ITD in cellular transformation
- BEX3
- Tyrosine 842 in the activation loop is required for full transformation by the oncogenic mutant FLT3-ITD